Understanding GLP-1 Discontinuation Rates
Half of the people who take GLP-1 drugs such as Ozempic quit within the first year. Why?
A Clockwork Ozempic?
A dialogue between Chris Hayes and Nicholas Reville on using GLP1-RA drugs to treat addiction.
The Endocannabinoid System and Addiction
New research looks at developing endocannabinoid receptor agonists for the treatment of obesity, PTSD and drug addiction.
GLP-1 Drugs and Alcohol Use Disorder
A pair of studies point to the same conclusion, that GLP-1 drugs are effective against alcohol use disorder (AUD).
Day One 2025: Accelerating Innovation in Addiction Treatment
The Federation of American Scientists lays out an agenda for accelerating innovation in addiction treatment.
New Homelessness Report Mysteriously Silent on Substance Use Disorders
HUD annual report shows a sharp rise in homelessness but says little about causes and cures.